MAINTENANCE BEVACIZUMAB (BV) WITH OR WITHOUT PEMETREXED (PEM) FOLLOWING FIRST-LINE BV-CISPLATIN (CIS)-PEM IN PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY SAFETY DATA FROM AVAPERL1 (MO22089) in ANNALS OF ONCOLOGY, vol 21, issue , pp 144-144

Barlesi, F (author)

University Aix Marseille 2

Pazzola, A (author)

NN Blokhin Russian Canc Research Centre

Grossi, F (author)

Natl Institute Canc Research, Genoa, Italy

show more...

Kohler, M (author)

Dr M Koehler Gmbh

Mezger, J (author)

St Vincentius Kliniken Karlsruhe

Peters, F J (author)

Orbis Med Centre

Trigo Perez, J M (author)

Hospital Clin University Virgen Victoria

Vikström, Anders (author)

Linköpings universitet,Institutionen för klinisk och experimentell medicin,Hälsouniversitetet

Groen, H J M (author)

University Med Centre Groningen

show less...

 (creator_code:org_t)

Oxford University Press, 2010

2010

English.

In: ANNALS OF ONCOLOGY. - : Oxford University Press. ; , s. 144-144

Related links:

https://urn.kb.se/re...

• Conference paper (peer-reviewed)